News

DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...
HIV prevention is entering a new phase with the rise of innovative medications like the twice-yearly injectable lenacapavir.
Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries.Manufactured by ...
DAP Health is presenting “Next Gen Care: A Community Conversation on HIV Prevention,” an event that will highlight ...
Although Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...
President Donald Trump is removing a large portion of HIV funding he previously greenlit for a future without AIDs. For ...
Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With ...
President Donald Trump is removing a large portion of HIV funding he previously greenlit for a future without AIDs. For ...
Patients are already receiving the new PrEP injectable option lenacapavir in the Bay Area, though issues with insurance are ...
Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...
WHO recommends twice-yearly injectable lenacapavir for HIV prevention, expanding PrEP options for key populations.